Riskpilot← Back to searchSign inGet full accessAbilion Medical Systems AB
ABActiveOrg 5590074349Tullvaktsvägen 2Research and experimental development on natural sciences and engineering · NACE 7210Est. 20151 employees
Revenue 2024
SEK 0
EBITDA margin
—
-148% vs 2023
Equity ratio
72.3%
Financial strength
Net profit 2024
SEK -5,8M
-133% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -5,4M | -148% |
| Net profit | SEK -5,8M | -133% |
| Total assets | SEK 2,5M | -46% |
| Equity | SEK 1,8M | -54% |
| Employees | 1 | — |
Legal name
Abilion Medical Systems AB
Org number
5590074349
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
16 mars 2015
Share capital
SEK 187 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska utveckla och marknadsföra medicintekniska produkter, att bedriva medicinsk forskning och behandling och därmed förenlig verksamhet.
Address
Tullvaktsvägen 2
Email
info@abilion.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −1 298 | −2 105 | −4 060 | −2 179 | −5 396 |
| Depreciation & amort. | −4 | −40 | −114 | −340 | −450 |
| EBIT | −1 302 | −2 145 | −4 174 | −2 519 | −5 846 |
| Net financials | −24 | −17 | −10 | 6 | 3 |
| Profit before tax | −1 326 | −2 162 | −4 184 | −2 513 | −5 843 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −1 326 | −2 162 | −4 184 | −2 513 | −5 843 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 217 | 1 137 | 2 762 | 4 665 | 2 503 |
| Equity | 2 888 | 725 | 1 896 | 3 957 | 1 810 |
| Long-term debt | 136 | 54 | 0 | 0 | 0 |
| Short-term debt | 194 | 358 | 866 | 708 | 693 |
| Total debt | 330 | 412 | 866 | 708 | 693 |
EBITDA margin
-539600000.0%
This company
15.8%
Market median
-3415189973% vs market
20202024
Equity ratio
72.3%
This company
38.2%
Market median
+89% vs market
20202024
Return on equity
-322.8%
This company
18.4%
Market median
-1854% vs market
20202024
Net profit margin
-584300000.0%
This company
8.1%
Market median
-7213580347% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.38×
This company
0.62×
Market median
+39% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JF Chief Auditor | Chief Auditor | 2025 |
KV Chief Executive Officer | Chief Executive Officer | 2021 |
| Former (2) | ||
FR Chief Executive Officer | Chief Executive Officer | 2020 – 2021 |
JB Chief Auditor | Chief Auditor | 2020 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2020 | |
| Board of Directors | 2020 | |
| Chairman | 2025 | |
| Former (2) | ||
| Deputy Board Member | 2020 – 2021 | |
| Chairman | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Abilion Medical Systems AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Fredrik Robert Juto | Chief Executive Officer | 0 companies |
| Johan Fredrik Danielsson | Chief Auditor | 0 companies |
| Joakim Bernt Viberg | Chief Auditor | 0 companies |
| Karl-Johan Verner Pantzar | Chief Executive Officer | 0 companies |
| Per Göran Friman | Board of Directors | 0 companies |
| Jan Erik Juto | Board of Directors | 0 companies |
| Erik Alexander Juto | Deputy Board Member | 0 companies |
| Per Svante Blomster | Chairman | 0 companies |
| Fredrik Sten Henckel | Chairman | 0 companies |